BOOM

Trending Searches

    SUPPORT
    BOOM

    Trending News

      • Fact Check 
        • Fast Check
        • Politics
        • Business
        • Entertainment
        • Social
        • Sports
        • World
      • Law
      • Explainers
      • News 
        • All News
      • Decode 
        • Impact
        • Scamcheck
        • Life
        • Voices
      • Media Buddhi 
        • Digital Buddhi
        • Senior Citizens
        • Videos
      • Web Stories
      • BOOM Research
      • BOOM Labs
      • Deepfake Tracker
      • Videos 
        • Facts Neeti
      • Home-icon
        Home
      • About Us-icon
        About Us
      • Authors-icon
        Authors
      • Team-icon
        Team
      • Careers-icon
        Careers
      • Internship-icon
        Internship
      • Contact Us-icon
        Contact Us
      • Methodology-icon
        Methodology
      • Correction Policy-icon
        Correction Policy
      • Non-Partnership Policy-icon
        Non-Partnership Policy
      • Cookie Policy-icon
        Cookie Policy
      • Grievance Redressal-icon
        Grievance Redressal
      • Republishing Guidelines-icon
        Republishing Guidelines
      • Fact Check-icon
        Fact Check
        Fast Check
        Politics
        Business
        Entertainment
        Social
        Sports
        World
      • Law-icon
        Law
      • Explainers-icon
        Explainers
      • News-icon
        News
        All News
      • Decode-icon
        Decode
        Impact
        Scamcheck
        Life
        Voices
      • Media Buddhi-icon
        Media Buddhi
        Digital Buddhi
        Senior Citizens
        Videos
      • Web Stories-icon
        Web Stories
      • BOOM Research-icon
        BOOM Research
      • BOOM Labs-icon
        BOOM Labs
      • Deepfake Tracker-icon
        Deepfake Tracker
      • Videos-icon
        Videos
        Facts Neeti
      Trending Tags
      TRENDING
      • #Operation Sindoor
      • #Pahalgam Terror Attack
      • #Narendra Modi
      • #Rahul Gandhi
      • #Waqf Amendment Bill
      • #Arvind Kejriwal
      • #Deepfake
      • #Artificial Intelligence
      • Home
      • Coronavirus
      • Remdesivir Shortage: Where Can You...
      Coronavirus

      Remdesivir Shortage: Where Can You Find This COVID-19 Antiviral?

      While the Indian government has stopped the export of the drug, the seven Indian manufacturers are trying to ramp up their production to meet the increasing demands

      By - Shachi Sutaria |
      Published -  17 April 2021 6:09 PM IST
    • Boomlive
      Remdesivir Shortage: Where Can You Find This COVID-19 Antiviral?

      India finds itself in the same position as last year with reports of shortage of the anti-viral Remdesivir doing the rounds on social media. As the number of cases increase, so does hospitalisation and the demand for this injection.

      This unmet demand with skewed supply has led to the shortage of this antiviral in hospitals as well as with distributors. The seven manufacturers who are producing this medicine are also running out of stock and the Department of Pharmaceuticals has decided to help them increase production after it banned the export of the drug on April 11. Currently, they have a capacity of 38.8 lakh doses per month and will require about a month's time to increase it.

      This anti-viral produced by Gilead Lifesciences based in the United States of America was first manufactured to fight Ebola but was not found to be effective against the disease. Approved by the US Food and Drug Administration for emergency use against SARS-CoV-2, the Remdesivir arm of the SOLIDARITY trial by the World Health Organisation found that the drug has little or no effect on overall mortality, initiation of ventilation and duration of hospital stay in hospitalized patients.

      Also Read:WHO Trial Finds Remdesivir Does Not Reduce COVID-19 Mortality

      Remdesivir is a part of India's COVID-19 treatment protocol but only as an investigational therapy. On April 13, in the weekly COVID-19 press conference, Dr. V K Paul, member NITI Aayog urged physicians to not prescribe the drug indiscriminately which was then leading to shortage. The drug was only to be given to hospitals for using for patients with severe symptoms.

      Despite the government's repeated insistence, there have been repeated requests on all social media platforms for Remdesivir along with Tocilizumab as stocks across cities run out.

      The government is also planning to cap the costs for the anti-viral injection that is sold in a 100ml vial. Cipla, Dr. Reddy's Laboratories, Hetero Labs, Jubilant Lifesciences, Mylan, Syngene, a Biocon company and Zydus Cadila Healthcare are the ones manufacturing the vaccine in the country and when it was approved and launched in the country, it was sold at over ₹4,000.

      During the shortage, last year as well as this year, it is being sold at four times the market price. The government has now requested the manufacturers to reduce the cost of the medicine. Zydus is selling its product at ₹829. All the other manufacturers have agreed to cap their prices below ₹3,500.

      Minister of Chemicals and Fertilizers, Mansukh Mandaviya has tweeted the reduced prices.

      Due to Government's intervention, the price of #Remdesivir Injection is now reduced!

      I am thankful to pharmaceutical companies for joining hands with the Government to fight against CoVID Pandemic. pic.twitter.com/dUh8Mvt4kA

      — Mansukh Mandaviya (@mansukhmandviya) April 17, 2021

      To ensure that procuring the medicine does not get more chaotic than it already is, the pharmaceuticals have released helpline numbers along with their distribution lists. Family members of patients can provide the hospital and doctor's prescription, along with the patient and their Aadhaar card numbers to avail of the stocks as well normally get details about the drug.

      Helpline Numbers For Remdesivir

      The National Pharmaceutical Pricing Authority, the apex body to ensure that there is no black marketing or predatory pricing, has launched a helpline for noting down grievances about non-availability of Remdesivir injection. They can be contacted on 1800 111 255

      Dr. Reddy's has launched a website which can be accessed at readytofightcovid.in. However, the website currently states that they are out of stock. They also have a 24-hour helpline- 1800-266-7080/ 18004250014

      Cipla has released a document with all its distributors across the country while they can also be reached out on info.availability@cipla.com. Their helpline number is 8657311088.

      Further are the posters released by Hetero and Mylan.





      In Mumbai, drug inspectors have been allocated to work over the issues in each ward. The helpline number for the Food and Drug Administration department is 1800222365.

      There are also several messages with numbers of distributors that are being shared on WhatsApp. Most of these distributors are same as in the list shared by Cipla.

      Also Read:Gujarat Govt's COVID-19 Data Do Not Match Ground Data: Gujarat HC

      BOOM's ground report from Mumbai shows how kin of patients have been left to their own means as the remdesivir stocks in hospitals are also depleting.



      Tags

      Remdesivir#Remdesivir injection priceCiplaIndiaCOVID-19
      Read Full Article
      Next Story
      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker. Please reload after ad blocker is disabled.
      X

      Subscribe to BOOM Newsletters

      👉 No spam, no paywall — but verified insights.

      Please enter a Email Address
      Subscribe for free!

      Stay Ahead of Misinformation!

      Please enter a Email Address
      Subscribe Now🛡️ 100% Privacy Protected | No Spam, Just Facts
      By subscribing, you agree with the Terms & conditions and Privacy Policy connected to the offer

      Thank you for subscribing!

      You’re now part of the BOOM community.

      Or, Subscribe to receive latest news via email
      Subscribed Successfully...
      Copy HTMLHTML is copied!
      There's no data to copy!